Chargement en cours...
Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients
OBJECTIVE: UroVysion (Abbott Molecular, Inc., Illinois, USA) is based on multicolor fluorescence in situ hybridization (FISH). It has been used successfully in the USA following its Food and Drug Administration approval in 2001. However, the technology was not approved for use in Japan until 2017. C...
Enregistré dans:
| Publié dans: | Asian Pac J Cancer Prev |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
West Asia Organization for Cancer Prevention
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6948889/ https://ncbi.nlm.nih.gov/pubmed/31030505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.4.1271 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|